Identifying Patients With Unrecognized Treatable Diabetic Macular Edema

Purpose

This trial will assess the incidence of new and/or undiagnosed diabetic macular edema (DME) in diabetic patients that undergo a DME screening exam. The screening exam will consist of medical history, Electronic ETDRS visual acuity assessment, SD-OCT and color fundus photography

Condition

  • Diabetic Macular Edema

Eligibility

Eligible Ages
Over 18 Years
Eligible Genders
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Ability to provide written informed consent and comply with study assessments for the full duration of the study - Age > 18 years - Patient related considerations - Patients with diabetes mellitus - Disease related considerations - Diabetes mellitus

Exclusion Criteria

  • Prior admission screening within twelve months. - Inability to sit for evaluation

Study Design

Phase
Study Type
Observational
Observational Model
Other
Time Perspective
Prospective

Recruiting Locations

MedStar Hospital
Baltimore, Maryland 21237

More Details

Status
Unknown status
Sponsor
Elman Retina Group

Study Contact

Jennifer Belz
4106863000
belz@elmanretina.com